4.6 Article

Therapeutic Potential of SOX2 Inhibition for Embryonal Carcinoma

Journal

JOURNAL OF UROLOGY
Volume 187, Issue 5, Pages 1876-1881

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.juro.2011.12.058

Keywords

testis; SOX2 protein, human; carcinoma, embryonal; neoplasms, germ cell and embryonal; RNA, small interfering

Funding

  1. Ministry of Education, Culture, Sports, Science, and Technology, Japan
  2. Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research
  3. Takeda Science Foundation
  4. Princess Takamatsu Cancer Research Fund [4-23603]
  5. Grants-in-Aid for Scientific Research [21592040] Funding Source: KAKEN

Ask authors/readers for more resources

Purpose: Some nonseminomatous germ cell tumors are resistant to any type of chemotherapy. Control of embryonal carcinoma cells is crucial to manage nonseminomatous germ cell tumors. We established SOX2 targeting therapy in an embryonal carcinoma model. Materials and Methods: SOX2 expression was evaluated in a series of testicular germ cell tumor tissue samples. The antitumor effect of SOX2 knockdown was analyzed in vitro and in vivo using an embryonal carcinoma model. Results: In testicular germ cell tumor tissue SOX2 was expressed in the foci of embryonal carcinoma but negative in seminoma and yolk sac tumors. In an embryonal carcinoma model SOX2-siRNA induced apoptotic cell death in vitro and significant growth suppression in vivo. Conclusions: This study shows the therapeutic potential of SOX2 silencing for embryonal carcinoma. However, further improvements are needed in SOX2-siRNA delivery to the tumor.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Superoxide dismutase 2 expression can predict prognosis of renal cell carcinoma patients

Tetsuya Yoshida, Susumu Kageyama, Takahiro Isono, Takeshi Yuasa, Ryoji Kushima, Akihiro Kawauchi, Tokuhiro Chano

CANCER BIOMARKERS (2018)

Review Biochemistry & Molecular Biology

Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy

Susumu Kageyama, Hiromi Ii, Keiko Taniguchi, Shigehisa Kubota, Tetsuya Yoshida, Takahiro Isono, Tokuhiro Chano, Taku Yoshiya, Kosei Ito, Tatsuhiro Yoshiki, Akihiro Kawauchi, Susumu Nakata

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Biochemistry & Molecular Biology

RAB39A: a Rab small GTPase with a prominent role in cancer stemness

Tokuhiro Chano, Sofia Avnet

JOURNAL OF BIOCHEMISTRY (2018)

Article Oncology

ADP-ribosylation factor-like 4C predicts worse prognosis in endometriosis-associated ovarian cancers

Shiro Wakinoue, Tokuhiro Chano, Tsukuru Amano, Takahiro Isono, Fuminori Kimura, Ryoji Kushima, Takashi Murakami

CANCER BIOMARKERS (2019)

Article Oncology

Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers

Tsukuru Amano, Tokuhiro Chano, Takahiro Isono, Fuminori Kimura, Ryoji Kushima, Takashi Murakami

WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)

Article Oncology

Pro-GA, a Novel Inhibitor of γ-Glutamylcyclotransferase, Suppresses Human Bladder Cancer Cell Growth

Eiki Hanada, Susumu Kageyama, Ryosuke Murai, Shigehisa Kubota, Hiromi Ii, Susumu Nakata, Hiroko Kita, Akihiro Kawauchi, Tokuhiro Chano

ANTICANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis

Keiko Taniguchi, Hiromi Ii, Susumu Kageyama, Hiroko Takagi, Tokuhiro Chano, Akihiro Kawauchi, Susumu Nakata

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Chemistry, Multidisciplinary

Preferential Tumor Accumulation of Polyglycerol Functionalized Nanodiamond Conjugated with Cyanine Dye Leading to Near-Infrared Fluorescence In Vivo Tumor Imaging

Fumi Yoshino, Tsukuru Amano, Yajuan Zou, Jian Xu, Fuminori Kimura, Yoshio Furusho, Tokuhiro Chano, Takashi Murakami, Li Zhao, Naoki Komatsu

SMALL (2019)

Article Oncology

Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells

Hiroko Takagi, Hiromi Ii, Susumu Kageyama, Eiki Hanada, Keiko Taniguchi, Taku Yoshiya, Tokuhiro Chano, Akihiro Kawauchi, Susumu Nakata

ANTICANCER RESEARCH (2019)

Article Orthopedics

Histopathological explanation of the MRI target sign in extra-axial schwannomas

Michihito Ishizawa, Hidetoshi Okabe, Keiji Matsumoto, Shigeru Morimoto, Sinsuke Hukuda, Tokuhiro Chano

Summary: In schwannomas of the extremities showing target sign in T2-weighted images, histopathologically, the peripheral areas were suggested to be mucinous degeneration of the epineurium or perineurium, while the central areas were composed of truly neoplastic cells.

JOURNAL OF ORTHOPAEDIC SCIENCE (2021)

Article Oncology

A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma

Shigehisa Kubota, Tetsuya Yoshida, Susumu Kageyama, Takahiro Isono, Takeshi Yuasa, Junji Yonese, Ryoji Kushima, Akihiro Kawauchi, Tokuhiro Chano

WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma

Tsukuru Amano, Atsushi Murakami, Takashi Murakami, Tokuhiro Chano

Summary: Ovarian clear cell carcinomas (OCCCs) are resistant to conventional anti-cancer drugs and often arise from endometriosis associated with strong oxidative stress. The oxidative stress tolerance properties are involved in the survival and cancer stemness of OCCC cells. Therapeutic approaches need improvement, with multi-combinatorial treatments expected to improve patient outcomes.

ANTIOXIDANTS (2021)

Review Health Care Sciences & Services

Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature Review

Tsukuru Amano, Tokuhiro Chano, Fumi Yoshino, Fuminori Kimura, Takashi Murakami

HEALTHCARE (2019)

Article Oncology

Acid microenvironment promotes cell survival o human bone sarcoma through the activation of clAP proteins and NE-κB pathway

Sofia Avnet, Tokuhiro Chano, Annamaria Massa, Gloria Bonuccelli, Silvia Lemma, Luigi Falzetti, Giulia Grisendi, Massimo Dominici, Nicola Baldini

AMERICAN JOURNAL OF CANCER RESEARCH (2019)

Article Oncology

ADP-ribosylation factor-like 4C is a predictive biomarker of poor prognosis in patients with renal cell carcinoma

Takahiro Isono, Tokuhiro Chano, Tetsuya Yoshida, Ai Makino, Shohei Ishida, Masafumi Suzaki, Susumu Kageyama, Akihiro Kawauchi, Junji Yonese, Takeshi Yuasa

AMERICAN JOURNAL OF CANCER RESEARCH (2019)

No Data Available